OXB.L - Oxford BioMedica PLC

LSE - LSE Delayed Price. Currency in GBp
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in GBP. All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue37,59027,77615,90913,618
Cost of Revenue18,44211,8355,8394,416
Gross Profit19,14815,94110,0709,202
Operating Expenses
Research Development21,61124,29920,27416,986
Selling General and Administrative7,2765,9576,7413,957
Non Recurring----
Others-4,071-3,002-2,862-1,128
Total Operating Expenses43,25839,08929,99224,231
Operating Income or Loss-5,668-11,313-14,083-10,613
Income from Continuing Operations
Total Other Income/Expenses Net-6,093-8,994-2,899-185
Earnings Before Interest and Taxes-5,668-11,313-14,083-10,613
Interest Expense-6,131-4,919-1,891-235
Income Before Tax-11,761-20,307-16,982-10,798
Income Tax Expense-2,744-3,666-3,963-2,137
Minority Interest----
Net Income From Continuing Ops-9,017-16,641-13,019-8,661
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-9,017-16,641-13,019-8,661
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-9,017-16,641-13,019-8,661